Spanish Red Biotech Pipeline

Amgen

bemarituzumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Digestive System
Indication: Previously untreated advanced gastric or gastroesophageal junction cancer with overexpression of FGFR2b
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain